Press releases

BD (Becton, Dickinson and Company) (NYSE: BDX) issued the following statement in response to receiving a warning letter from the U.S. Food and Drug Administration for its Preanalytical Systems...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance by the Ministry of Commerce of the People's...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance by the U.S. Federal Trade Commission (FTC)...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has established a Product Security Partnership Program that emphasizes collaboration...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today revealed several technology innovations to further optimize the entire medication management...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight(TM) platform...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's announcement by Merit Medical Systems, Inc. that it...

Click on the links below to view results for the 2017 fourth fiscal quarter and full year: View document online PDF file of BD 2017 fourth fiscal quarter and full year results About BD BD is one...

Mississauga, Ontario, Oct. 26, 2017 – In recognition of Canadian Patient Safety Week (CPSW), occurring Oct. 30 – Nov.3, BD (Becton, Dickinson and Company), a leading global medical technology...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to break ground on a $60...

Mississauga, Ontario and Hamilton, Ontario - September 28, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company and the Canadian Society for Medical Laboratory...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch(1) of the first automated phenotypic test to detect and classify...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Euroclone (Euroclone Diagnostica Srl) today announced a development and global distribution...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the BD Ultra-Fine(TM) micro pen needle 6mm x 32G for use with...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to...

SAN DIEGO, Aug. 28, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, Direct Relief and the National Association of Community Health Centers...

FRANKLIN LAKES, N.J., August 14, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...

Click on the links below to view results for 2017 Third Fiscal Quarter: View Document Online PDF File of BD 2017 Third Fiscal Quarter Results About BD BD is one of the largest global medical...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new technology that can automatically report and release negative urine cultures. Every...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its new line of Snowden-Pencer((TM)) 3.0mm laparoscopic ergonomic take-apart...

ASHLAND, Ore and FRANKLIN LAKES, N.J., June 13, 2017 ─ FlowJo, LLC, a life science informatics and data analysis company with 20 years of experience in software for analyzing single-cell data,...

FRANKLIN LAKES, N.J., June 6, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2016 Sustainability Report. BD’s...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its newly developed molecular test for detecting harmful intestinal bacteria...